Autres langues Coherus BioSciences, Inc.

Actions

CHRS

US19249H1032

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
2,17 ^USD	+5,34%		+12,44%	-34,83%

24/04	Coherus BioSciences, Inc. annonce la présentation de données cliniques sur le CHS-114 lors de la réunion annuelle de l'American Society of Clinical Oncology en 2024	CI
21/03	COHERUS BIOSCIENCES, INC. : HC Wainwright favorable sur le dossier	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Coherus to Report First Quarter 2024 Financial Results on May 9, 2024	01/05
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology Annual Meeting	25/04
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24/04
Coherus BioSciences, Inc. Announces Presentation of Clinical Data for CHS-114 at 2024 American Society of Clinical Oncology Annual Meeting	24/04
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting	08/04
Coherus BioSciences Shares Fall After Workforce Reduction Plan; Q4 Loss	14/03
Coherus BioSciences: Q4 Earnings Snapshot	13/03
Earnings Flash (CHRS) COHERUS BIOSCIENCES Reports Q4 Revenue $91.5M, vs. Street Est of $90.4M	13/03
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update	13/03
Coherus BioSciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	13/03
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	07/03
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024	05/03
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024	05/03
North American Morning Briefing : Stock Futures -2-	04/03
North American Morning Briefing : Stock Futures Hover At Start of Busy Week	04/03
Coherus BioSciences Completes $170 Million Sale of Ophthalmology Franchise to Sandoz	04/03
Sandoz : acquisition de Cimerli finalisée	04/03
EN DIRECTO DESDE LOS MERCADOS: Santander, Endesa, Acciona, Amadeus, Repsol, Evonik, Geox, Volkswagen...	04/03
Sandoz schliesst Übernahme von Biosimilar Cimerli erfolgreich ab	04/03
Sandoz Completes Purchase of Retinal Disease Medication Cimerli from Coherus BioSciences	04/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Coherus BioSciences, Inc.

Actions

CHRS

US19249H1032

Autres langues

Filtres